Ivermectin in the treatment of COVID-19-friend or foe?

被引:0
|
作者
Schellack, N. [1 ]
Padayachee, N. [2 ]
Schellack, G. [3 ]
机构
[1] Univ Pretoria, Pretoria, South Africa
[2] Univ Witwatersrand, Clin Pharm, Dept Pharm & Pharmacol, Johannesburg, South Africa
[3] Clin Res & Appl Pharmacol, Cape Town, South Africa
关键词
COVID-19; SARS-CoV-2; ivermectin; avermectin; macrocyclic lactone; endectocide; ADVERSE-REACTIONS; SAFETY; PHARMACOKINETICS; PROTEIN; DENGUE; DRUG;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The global number of deaths due to COVID-19 is almost at the two million mark, with over 35 000 deaths in South Africa. Although there are hopes of a safe and effective vaccination programme, the increasing number of COVID-19 cases in the country is putting a significant strain on the healthcare system. Ivermectin, an antiparasitic drug, has been widely published on social media platforms and news outlets as a so-called miracle drug for the treatment of COVID-19. Ivermectin is not registered in SA as a drug for human use, but rather as a veterinary and agricultural product. Currently, from a small number of randomised controlled trials (RCTs), there does seem to be a signal of evidence for the use of ivermectin in the management of COVID-19. Pharmacists must, however, remain cognisant of their ethical responsibilities as well as the applicable regulations that prohibit the procurement and dispensing of any unregistered medicine.
引用
收藏
页码:11 / +
页数:5
相关论文
共 50 条
  • [21] Altitude and COVID-19: Friend or foe? A narrative review
    Millet, Gregoire P.
    Debevec, Tadej
    Brocherie, Franck
    Burtscher, Martin
    Burtscher, Johannes
    [J]. PHYSIOLOGICAL REPORTS, 2021, 8 (24):
  • [22] Platelets in COVID-19 disease: friend, foe, or both?
    Marta Smęda
    Ebrahim Hosseinzadeh Maleki
    Agnieszka Pełesz
    Stefan Chłopicki
    [J]. Pharmacological Reports, 2022, 74 : 1182 - 1197
  • [23] The role of ACEIs/ARBs in COVID-19: Friend or foe?
    Zhou, Zhe
    Qiu, Yumin
    Tao, Jun
    [J]. MEDICAL HYPOTHESES, 2020, 142
  • [24] VITAMIN D SUPPLEMENTATION IN COVID-19: A FRIEND OR FOE?
    Mansour, Asieh
    Mohajeri-Tehrani, Mohammad Reza
    Sajjadi-Jazi, Sayed Mahmoud
    [J]. EXCLI JOURNAL, 2020, 19 : 1166 - 1168
  • [25] IL-33 in COVID-19: friend or foe?
    Yuejin Liang
    Yiyue Ge
    Jiaren Sun
    [J]. Cellular & Molecular Immunology, 2021, 18 : 1602 - 1604
  • [26] Saliva-Friend and Foe in the COVID-19 Outbreak
    Han, Pingping
    Ivanovski, Saso
    [J]. DIAGNOSTICS, 2020, 10 (05)
  • [27] Innate T cells in COVID-19: friend or foe?
    van der Heide V.
    [J]. Nature Reviews Immunology, 2020, 20 (7) : 407 - 407
  • [28] Baricitinib as Treatment for Coronavirus Disease 2019 (COVID-19): Friend or Foe of the Pancreas? Reply
    Titanji, Boghuma K.
    Farley, Monica M.
    Schinazi, Raymond F.
    Marconi, Vincent C.
    [J]. CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) : E3978 - E3979
  • [29] Ivermectin Treatment for Covid-19
    Furlan, Leonardo
    Mejia, Jorge H.
    Jimenez, Carlos A. J.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 387 (24):
  • [30] Ivermectin Treatment for COVID-19
    Ohe, Masashi
    [J]. EWHA MEDICAL JOURNAL, 2021, 44 (04): : 146 - 147